Novavax Advances Development of Novel COVID-19 Vaccine

Go back to Novavax Advances Development of Novel COVID-19 Vaccine
Novavax, Inc. (NASDAQ: NVAX) Delayed: 7.93 -0.14 (1.73%)
Previous Close $8.07    52 Week High $9.23 
Open $7.97    52 Week Low $1.16 
Day High $8.08    P/E N/A 
Day Low $7.84    EPS $-0.30 
Volume 2,010,404       

Novavax, Inc. (NASDAQ: NVAX) Delayed: 7.93 -0.14 (1.73%)
Previous Close $8.07    52 Week High $9.23 
Open $7.97    52 Week Low $1.16 
Day High $8.08    P/E N/A 
Day Low $7.84    EPS $-0.30 
Volume 2,010,404